Cell therapy biotech nabs Series A; Metagenome startup snags $77M round
A cancer cell therapy biotech has reeled in about $20 million to push forward its ongoing Phase I.
Alloplex Biotherapeutics has secured about $20 million …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
